SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001628280-24-004464
Filing Date
2024-02-13
Accepted
2024-02-13 16:12:05
Documents
2
Group Members
BRIAN TAYLOR SLINGSBYCATALYS PACIFIC FUND GP, LPCATALYS PACIFIC FUND, LPCATALYS PACIFIC, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G a2024021313g.htm SC 13G 111546
2 EX-99.1 a2024021313gex991.htm EX-99.1 12457
  Complete submission text file 0001628280-24-004464.txt   125857
Mailing Address 301 9-19 HACHIYAMA, SHIBUYA TOKYO M0 150-0035
Business Address 301 9-19 HACHIYAMA, SHIBUYA TOKYO M0 150-0035 81 90-3536-3820
Catalys Pacific Fund, LP (Filed by) CIK: 0001746274 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Subject) CIK: 0001933414 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94000 | Film No.: 24625989
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)